Tirzepatide 15 mg was also associated with higher incidence of vomiting (OR 5.50 [95% CI 2.40, 12.59], I 2 0%) and diarrhoea (OR 3.31 [95% CI 1.40, 7.85], I 2 52%), while more participants receiving tirzepatide 10 mg experienced vomiting (OR 2.98 [95% CI 1.13, 7.80], I 2 0%) (Table 2)
Unless you were deep into bodybuilding forums, anti ageing circles or underground performance communities, most people had never even heard the word
Dig Dis Sci
Archives of Medical Research 46 (7): 527533
Links mentioned in this episode Perimenopause weight loss plan Insulin resistance episode: what labs to check Perimenopause weight loss episode Two-part sleep series (why sleep shifts appetite, cortisol, and metabolic health): Part 1, Part 2 Thyroid deep dives with McCall McPherson (thyroid panels and GLP-1 considerations)